684
Views
125
CrossRef citations to date
0
Altmetric
REVIEW

Nitric Oxide Mechanism of Protection in Ischemia and Reperfusion Injury

, , MD, , MD, MS, , MD, PhD & , MD, PhD
Pages 46-55 | Received 15 Sep 2008, Accepted 18 Sep 2008, Published online: 09 Jul 2009

REFERENCES

  • Yetik-Anacak G, Catravas J D. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vascul Pharmacol 2006; 45: 268–276
  • Moncada S, Higgs E A. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 2006; 147: S193–S201
  • Miller M R, Megson I L. Recent developments in nitric oxide donor drugs. Br J Pharmacol 2007; 151: 305–321
  • Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61: 402–413
  • Gkaliagkousi E, Ritter J, Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res 2007; 101: 654–662
  • Anaya-Prado R, Toledo-Pereyra L H, Lentsch A B, et al. Ischemia/Reperfusion Injury. J Surg Res 2002; 105: 248–258
  • Ohmori H, Dhar D K, Nakashima Y, et al. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver. Exp Transplant 1998; 66: 579–585
  • Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 2001; 33: 1897–1918
  • Aiba M, Takeyoshi I, Ohwada S, et al. Novel nitric oxide donor (FK409) ameliorates liver damage during extended liver resection with warm ischemia in dogs. J Am Coll Surg 2001; 193: 264–271
  • Murakami S, Bacha E A, Mazmanian G M, et al. Effects of various timings and concentrations of inhaled nitric oxide in lung ischemia-reperfusion. Am J Respir Crit Care Med 1997; 156: 454–458
  • López-Neblina F, Toledo-Pereyra L H, Mirmiran R, et al. Time dependence of Na-Nitroprusside administration in the prevention of neutrophil infiltration in the rat ischemic kidney. Exp Transplant 1996; 61: 179–183
  • Jones S P, Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 2006; 40: 16–23
  • Weinberger B, Heck D E, Laskin D L, et al. Nitric oxide in the lung: therapeutic and cellular mechanisms of action. Pharmacol Ther 1999; 84: 401–411
  • Szabó C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007; 6: 662–680
  • Chander V, Chopra K. Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats. J Surg Res 2005; 128: 132–139
  • Massoudy P, et al. Nitric oxide accounts for postischemic cardioprotection resulting from angiotensin-converting enzyme inhibition: indirect evidence for a radical scavenger effect in isolated guinea pig hearts. J Cardiovasc Pharmacol 1995; 25: 440–447
  • Moncada S, Erusalimsky J D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev 2002; 3: 214–220
  • Brown G C, Borutaite V, et al. Serial review: nitric oxide in mitochondria. Free Radic Biol Med 2002; 33: 1440–1450
  • Lundberg J O, Weitzberg E, Gladwin M T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7: 156–166
  • Kanner J, Harel S, Granit R. Nitric oxide as an antioxidant. Arch Biochem Biophys 1991; 289: 130–136
  • Kawachi S, Hines I N, Laroux F S, et al. Nitric oxide synthase and postischemic liver injury. Biochem Biophys Res Commun 2000; 276: 851–854
  • Rodriguez-Peña A, Garcia-Criado F J, Eleno N, et al. Intrarenal administration of molsidomine, a molecule releasing nitric oxide, reduces renal ischemia-reperfusion injury in rats. Am J Transplant 2004; 4: 1605–1613
  • López-Neblina F, Páez A J, Toledo-Pereyra L H. Modulation of neutrophil infiltration through nitric oxide in the ischemic rat kidney. Transplant Proc 1995; 27: 1883–1885
  • De Caterina R, Libby P, Peng H B, et al. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 1995; 96: 60–68
  • Appelberg R. Macrophage inflammatory proteins MIP-1 and MIP-2 are involved in T cell-mediated neutrophil recruitment. J Leukoc Biol 1992; 52: 303–306
  • Suzuki S, Toledo-Pereyra L H. Interleukin-1 and tumor necrosis factor alpha production as the initial stimulant of liver ischemia and reperfusion injury. J Surg Res 1994; 57: 253–258
  • Frangogiannis N G. Chemokines in ischemia and reperfusion. Thromb Haemost 2007; 97: 738–747
  • López-Neblina F, et al. Control de daño postisquémico a través del bloqueo del TNF-alfa con óxido nítrico. Una neuva vía metabólica de control inflamatorio?. Cir Gen 1996; 4: 57
  • Anaya-Prado R, Toledo-Pereyra L H, Walsh J, et al. Exogenous nitric oxide donor and related compounds protect against lung inflammatory response after hemorrhagic shock and resuscitation. J Trauma 2004; 57: 980–988
  • Hatano E, Bennett B L, Manning A M, et al. NF-κ B stimulated inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α and FAS-mediated apoptosis. Gastroenterology 2001; 120: 1251–1262
  • Franco-Gou R, Roselló-Catafau J, Casillas-Ramirez A, et al. How ischemic preconditioning protects small liver grafts. J Pathol 2006; 208: 62–73
  • Martinez-Mier G, Toledo-Pereyra L H, Ward P A. Adhesion molecules in liver ischemia and reperfusion. J Surg Res 2000; 94: 185–194
  • Martinez-Mier G, Toledo-Pereyra L H, McDuffie E, et al. l-Selectin and chemokine response after liver ischemia and reperfusion. J Surg Res 2000; 93: 156–162
  • Martinez-Mier G, Toledo-Pereyra L H, McDuffie J E, et al. P-selectin and chemokine response after liver ischemia and reperfusion. J Am Coll Surg 2000; 4: 395–402
  • Lefer A M, Lefer D J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996; 32: 743–751
  • Waldow T, Witt W, Weber E, et al. Nitric oxide donor-induced persistant inhibition of cell adhesion protein expression and NF-κ B activation in endothelial cells. Nitric Oxide 2006; 15: 103–113
  • Jiang M Z, Tsukahara H, Hayakawa K, et al. Effects of antioxidants and NO on TNF-α -induced adhesion molecule expression in human pulmonary microvascular endothelial cells. Respir Med 2005; 99: 580–591
  • Carreras M C, Poderoso J J. Mitochondrial nitric oxide in the signaling of cell integrated responses. Am J Physiol Cell Physiol 2007; 292: C1569–C1580
  • Tarr J M, Eggleton P, Winyard P G. Nitric oxide and the regulation of apoptosis in tumour cells. Curr Pharm Des 2006; 12: 4445–4468
  • Shen Y H, Wang X L, Wilcken D E. Nitric oxide induces and inhibits apoptosis through different pathways. REBS Lett 1998; 433: 125–131
  • Kim P K, Zamora R, Petrosko P, et al. The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 2001; 1: 1421–1441
  • Choi B M, Pae H O, Jang S I, et al. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. Biochem Mol Biol 2002; 35: 116–126
  • Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 61: 402–413
  • Martinez-Mier G, Toledo-Pereyra L H, Bussell S, et al. Nitric oxide diminishes apoptosis and p53 gene expression after renal ischemia and reperfusion injury. Transplantation 2000; 70: 1431–1437
  • Boyd C S, Cadenas E. Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis. Biol Chem 2002; 383: 411–423
  • Wang H, Wang Z, Chen J, et al. Apoptosis by NO via phosphorylation of p38 MAPK that stimulates NF-κ B, p53 and caspase-3 activation in rabbit articular chondrocytes. Cell Biol Int 2007; 31: 1027–1035
  • Dimmeler S, Haedeler J, Nehls M, et al. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β -converting enzyme (ICE)-like and cysteine protease protein (CPP)-32)-like proteases. J Exp Med 1997; 185: 601–607
  • Kim Y M, de Vera M E, Watkins S C, et al. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997; 272: 1402–1411
  • Yamashita H, Akamine S, Sumida Y, et al. Inhaled nitric oxide attenuates apoptosis in ischemia-reperfusion injury of the rabbit lung. Ann Thorac Surg 2004; 75: 292–297
  • Chung H T, Pae H O, Choi B M, et al. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Comm 2001; 282: 1075–1079
  • Martinez-Mier G, Toledo-Pereyra L H, McDuffie J E, et al. Exogenous nitric oxide downregulates MIP-2 and MIP-1α chemokines and MAPK p44/42 after ischemia and reperfusion of the rat kidney. J Invest Surg 2002; 15: 287–296
  • Chandrasekar B, Smith J B, Freeman G L. Ischemia-reperfusion of rat myocardium activates nuclear factor-kB and induces neutrophil infiltration via lipopolysaccharide-induced CSC chemokine. Circulation 2001; 103: 2296–2302
  • Kurosaka K, Takahashi M, Kobayashi Y. Activation of extracellular signal-related kinase is involved in production of CXC-chemokine by macrophages during phagocytosis of late apoptotic cells. Biochem Biophys Res Comm 2003; 306: 1070–1074
  • Shibata T, Nagata K, Kobayashi Y. Pivotal advance: a suppressive role of nitric oxide in MIP-2 production by macrophages upon coculturing with apoptotic cells. J Leukocyte Biol 2006; 80: 744–752
  • Walpen S, Beck K F, Schaefer L, et al. Nitric oxide induced MIP-2 transcription in rat renal mesangial cells and in a rat model of glomerulonephritis. FASEB J 2001; 15: 571–573
  • Yong T, Meijia Z, Haiyan H, et al. Regulation between nitric oxide and MAPK signal transduction in mammals. Prog Natural Sci 2005; 15: 1–9
  • Toledo-Pereyra L H, Toledo A H, Walsh J, et al. Molecular signaling pathways in ischemia/reperfusion. Exp Clin Transplant 2004; 2: 174–177
  • Rakhit R D, Kabir A N, Mockridge J W, et al. Role of G proteins and modulation of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation injury. Biochem Biophys Res Commun 2001; 286: 995–1002
  • Carini R, Grazia De Cesaris M, Splendore R, et al. Signal pathway responsible for hepatocyte preconditioning by nitric oxide. Free Radic Biol Med 2003; 34: 1047–1055
  • Madhusoodanan K S, Murad F. NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res 2007; 32: 681–694
  • von Knethen A, Callsen D, Brüne B. NF-κ B and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol Biol Cell 1999; 10: 361–372
  • Kim S H, Johnson V J, Sharma R P. Mercury inhibits nitric oxide production but activates proinflammatory cytokine expression in murine macrophage: differential modulation of NF-κ B and p38 MAPK signaling pathways. Nitric Oxide 2002; 7: 67–74
  • Spiecker M, Darius H, Kaboth K, et al. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukocyte Biol 1998; 63: 732–739
  • Hattori Y, Kasai K, Gross S S. NO suppresses while peroxynitrite sustains NF-κ B: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc Res 2004; 63: 31–40
  • Bogdan C. Nitric oxide and the regulation of gene expression. Trends Cell Biol 2001; 11: 66–75
  • Matthews J R, Botting C H, Panico M, et al. Inhibition of NF-κ B DNA binding by nitric oxide. Nucleic Acids Res 1996; 24: 2236–2242
  • Melino G, Bernassola F, Catani M V, et al. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Cancer Res 2000; 60: 2377–2383
  • Tabuchi A, Oh E, Taoka A, et al. Rapid attenuation of AP-1 transcriptional factors associated with nitric oxide (NO)-mediated neuronal cell death. J Biol Chem 1996; 271: 31061–31067
  • Shimamura T, Zhu Y, Zhang S, et al. Protective role of nitric oxide in ischemia and reperfusion injury of the liver. J Am Coll Surg 1999; 188: 43–52
  • King R C, Binns O A, Kanithanon R C, et al. Low-dose sodium nitroprusside reduces pulmonary reperfusion injury. Ann Thorac Surg 1997; 63: 1398–1404
  • Garcia-Criado F J, Eleno N, Santos-Benito F, et al. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion. Exp Transplant 1998; 66: 982–990
  • Brunton L L, Lazo J S, Parker K L. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed. McGraw-Hill, New York 2006
  • Sipe E K, Trienski T L, Porter J M. Cyanide toxicity in the surgical intensive care unit: a case report. Am Surg 2001; 67: 684–686
  • Friederich J A, Butterworth J F, 4th. Sodium nitroprusside: twenty years and counting. Anesth Analg 1995; 81: 152–162
  • Mason R P, Cockcroft J R. Targeting nitric oxide with drug therapy. J Clin Hypertens 2006; 8: 40–52
  • López-Neblina F, Paez A J, Toledo A H, et al. Role of nitric oxide in ischemia/reperfusion of the rat kidney. Circ Shock 1995; 44: 91–95
  • Kuroki I, Miyazaki T, Mizukami I, et al. Effect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver. Hepato-Gastroenterology 2004; 51: 1404–1407
  • Massoudy P, Zahler S, Freyholdt T, et al. Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances. J Thorac Cardiovasc Surg 2000; 119: 566–574
  • Yamashita M, Schmid R A, Ando K, et al. Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thoracic Surg 1996; 62: 791–797
  • Ohmori H, Dhar D K, Nakashima Y, et al. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver. Exp Transplant 1998; 66: 579–585
  • Muscará M N, Wallace J L. Nitric oxide V. Therapeutic potential of nitric oxide donors and inhibitors. American J Physiol 1999; 276: G1313–G1316
  • Katsumi T, et al. Development of nitric oxide donors for the treatment of cardiovascular diseases. Cardiovasc Hematoll Agents Med Chem 2007; 5: 204–208
  • Lowe C G, Trautwein J G. Inhaled nitric oxide therapy during the transport of neonates with persistant pulmonary hypertension or severe hypoxic respiratory failure. Eur J Pediatr 2007; 166: 1025–1031
  • Bloch K D, Ichinose F, Roberts J D, et al. Inhaled NO as a therapeutic agent. Cardiovasc Res 2007; 2: 339–348
  • Barbotin-Larrieu F, Mazmanian M, Baudet B, et al. Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J Appl Physiol 1996; 80: 782–788
  • Schütte H, Witzenrath M, Mayer K, et al. Short-term “preconditioning” with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplant 2001; 72: 1363–1370
  • Liu X, Huang Y, Pokreisz P, et al. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 2007; 50: 808–817
  • Lang J D, Jr, Teng X, Chumley P, et al. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007; 117: 2583–2591
  • Chattopadhyay P, Verma N, Verma A, et al. L-Arginine protects from pringle manoeuvere of ischemia-reperfusion-induced liver injury. Biol Pharm Bull 2008; 31: 890–892
  • Rusai K, Fekete A, Szebeni B, et al. Effect of inhibition of neuronal nitric oxide synthase and L-arginine supplementation on renal ischemia-reperfusion injury and the renal nitric oxide system. Clin Exp Pharmacol Physiol 2008; 35(10)1183–1189
  • López-Neblina F, et al. Role of nitric oxide in ischemia/reperfusion of the rat kidney. Circ Shock 1995; 44: 91–95
  • Aiba M, et al. Novel nitric oxide donor (FK409) ameliorates liver damage during extended liver resection with warm ischemia in dogs. J Am Coll Surg 2001; 193: 264–271
  • Cakir O, Oruc A, Eren S, et al. Does sodium nitroprusside reduce lung injury under cardiopulmonary bypass?. Eur J Cardiothorac Surg 2003; 23: 1040–1045
  • Anaya-Prado R, Toledo-Pereyra L H, Guo R F, et al. The attenuation of hemorrhage-induced liver injury by exogenous nitric oxide, L-arginine, and inhibition of inducible nitric oxide synthase. J Invest Surg 2003; 16: 247–261
  • Garreffa A M, Woodman O L, Cao A H, et al. Sodium nitroprusside protects adult rat cardiac myocytes from cellular injury induced by stimulated ischemia. J Cardiovasc Pharm 2006; 47: 1–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.